NASDAQ · MRVL
Marvell Technology, Inc.
$218.34-$33.31 (-13.24%)
Marvell Technology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.81% below the high.
Loading market information…
CNQ · IMCC.CN · CAD
Stock price, earnings
Quote as of Jun 2, 2025, 07:41 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
IM Cannabis Corp.’s quoted price sits in the lower half of its reported 52-week range, 47.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow IM Cannabis Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
IM Cannabis Corp. is engaged in the cultivation, processing, and supply of medical cannabis products across its operational territories of Israel, Germany, and Canada. The company's product portfolio features cannabis flowers and distinctive, strain-specific extracts marketed under its IMC brand. Additionally, it offers dried flower, pre-rolls, and pressed hash through its WAGNERS and Highland Grow labels. IM Cannabis Corp. caters to a diverse customer base, including medical patients and adult-use recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:35 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| CA$12.06M+13.8% vs estimate |
| Q4 2023 | Mar 28, 2024 | -CA$0.25-47.06% vs estimate | CA$10.70M+2.39% vs estimate |
|---|
| Q3 2023 | Nov 13, 2023 | -CA$0.16+23.81% vs estimate | CA$12.37M-6.99% vs estimate |
|---|
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$218.34-$33.31 (-13.24%)
Marvell Technology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.81% below the high.
CA$0.20-CA$0.01 (-4.76%)
Vinergy Capital Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.22-CA$0.01 (-4.35%)
Salona Global Medical Device Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.0% below the high.
CA$1.42-CA$0.04 (-2.74%)
Reunion Neuroscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.96% below the high.
CA$0.20CA$0.00 (0.0%)
EXMceuticals Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.23CA$0.00 (0.0%)
Chalice Brands Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.10-CA$0.01 (-4.76%)
RIV Capital Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.40CA$0.00 (0.0%)
Orion Nutraceuticals Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
